Effective treatment to relieve indwelling ureteral stent symptoms

Not Applicable

• Conditions: Symptoms of indwelling ureteral stent.; Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system - Unspecified complication of genitourinary prosthetic device, implant and graft; T83.5 , T8

• Registration Number: IRCT138812173509N1
• Lead Sponsor: Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

Ureteral stenting for treatment of ureteral obstruction due to upper tract urinary stone (kidney or ureter)
Exclusion criteria: history of urinary system surgery, BPH (IPSS>7), long standing lower urinary tract symptoms, Indwelling ureteral stent at presentation, treatment with NSAIDs or Alpha-blockers, advanced cardiac or hepatic disease, Pregnancy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relieving of indwelling ureteral stent symptoms. Timepoint: 1 week and 4 weeks after insertion, 1 week after removal. Method of measurement: Ureteral stent symptom score questionnaire (USSQ).

Secondary Outcome Measures

Name	Time	Method
Presence of indwelling ureteral stent symptoms in spite of medication. Timepoint: 1 week and 4 weeks after insertion, 1 week after removal. Method of measurement: Ureteral stent symptom score questionnaire (USSQ).